Stock pick for 2024: Buy Smith & Nephew for continued recovery and re-rating potential
Tentative signs of sustainable margin improvement and market share gains, combined with the tailwind provided by continued recovery in elective procedures, should provide medical products company Smith & Nephew (SN.) with positive...
21 December 2023
